-0.80%
-3.48%
-16.82%
-28.91%
11.83%
-66.15%
-48.52%
AI Spotlight on IGC
Company Description
India Globalization Capital, Inc.purchases and resells physical infrastructure commodities.It operates through two segments, Infrastructure and Life Sciences.
The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts.It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand.The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts.
It operates in the United States, India, Colombia, and Hong Kong.The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Market Data
| Last Price | 0.32 |
| Change Percentage | -0.80% |
| Open | 0.33 |
| Previous Close | 0.33 |
| Market Cap ( Millions) | 25 |
| Volume | 159765 |
| Year High | 0.91 |
| Year Low | 0.27 |
| M A 50 | 0.36 |
| M A 200 | 0.41 |
Financial Ratios
| FCF Yield | -21.26% |
| Dividend Yield | 0.00% |
| ROE | -158.95% |
| Debt / Equity | 4.12% |
| Net Debt / EBIDTA | 14.32% |
| Price To Book | 3.34 |
| Price Earnings Ratio | -1.96 |
| Price To FCF | -4.7 |
| Price To sales | 21.23 |
| EV / EBITDA | -2.75 |
News
- Jan -28 - IGC Pharma, Inc. (IGC) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Jan -28 - IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease
- Jan -13 - IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
- Jan -08 - IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy
- Dec -20 - IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025
- Dec -18 - What Makes IGC Pharma, Inc. (IGC) a New Buy Stock
- Nov -25 - IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
- Nov -14 - IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer's Pipeline
- Nov -06 - IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies
- Oct -17 - IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
- Oct -03 - IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
- Sep -23 - Nokia deploys high-performance cross-border DWDM network for IGC
- Sep -18 - IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
- Sep -04 - IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease
- Aug -09 - IGC Pharma Reports First Quarter Fiscal 2025 Results
- Jul -09 - Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
- Jun -25 - IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
- Jun -24 - IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
- Jun -18 - IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
- Jun -10 - IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Life Sciences
Expected Growth : 25.9 %
What the company do ?
Life Sciences from India Globalization Capital, Inc. is a biotech company focused on developing cannabinoid-based therapies for rare diseases and opioid replacement.
Why we expect these perspectives ?
Growing demand for cannabinoid-based therapies, increasing prevalence of rare diseases, and opioid epidemic drive growth. India Globalization Capital's focus on developing innovative treatments positions it for success in this expanding market.
Segment n°2 -> Infrastructure
Expected Growth : 12.3 %
What the company do ?
India Globalization Capital, Inc.'s infrastructure segment focuses on providing infrastructure services, including heavy construction, commercial and residential building, and infrastructure development.
Why we expect these perspectives ?
India's growing population, urbanization, and government initiatives like 'Smart Cities' and 'Housing for All' drive demand for infrastructure development, positioning India Globalization Capital, Inc.'s infrastructure segment for growth.
India Globalization Capital, Inc. Products
| Product Range | What is it ? |
|---|---|
| Hyalolex | A patented, plant-based cannabinoid product for the treatment of Alzheimer's disease |
| Natasha | A line of CBD-based products for the treatment of pain, anxiety, and sleep disorders |
| Sativum | A line of CBD-based products for the treatment of skin care and beauty |
| Data Analytics | Data analytics services for the cannabis industry |
| Blockchain-based Supply Chain Management | A blockchain-based platform for tracking and verifying cannabis products |
India Globalization Capital, Inc.'s Porter Forces
Threat Of Substitutes
The threat of substitutes for India Globalization Capital, Inc. is medium due to the presence of alternative investment options for investors.
Bargaining Power Of Customers
The bargaining power of customers for India Globalization Capital, Inc. is low due to the company's diversified investment portfolio and lack of dependence on a single customer.
Bargaining Power Of Suppliers
The bargaining power of suppliers for India Globalization Capital, Inc. is medium due to the company's reliance on a few key suppliers for its investment activities.
Threat Of New Entrants
The threat of new entrants for India Globalization Capital, Inc. is high due to the relatively low barriers to entry in the investment management industry.
Intensity Of Rivalry
The intensity of rivalry for India Globalization Capital, Inc. is high due to the presence of several established players in the investment management industry.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 3.12% |
| Debt Cost | 3.95% |
| Equity Weight | 96.88% |
| Equity Cost | 12.11% |
| WACC | 11.85% |
| Leverage | 3.23% |
India Globalization Capital, Inc. : Quality Control
India Globalization Capital, Inc. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| TRC | Tejon Ranch Co., together with its subsidiaries, operates as a diversified real estate development and agribusiness company. It operates through five segments: Commercial/Industrial Real Estate Development, Resort/Residential Real Estate Development, … |
| TUSK | Mammoth Energy Services, Inc. operates as an energy service company. The company operates in four segments: Infrastructure Services, Well Completion Services, Natural Sand Proppant Services, and Drilling Services. The Infrastructure … |
| NNBR | NN, Inc., a diversified industrial company, designs, manufactures, and sells high-precision components and assemblies. It operates through two segments, Mobile Solutions and Power Solutions. The Mobile Solutions segment manufactures and … |
| RCMT | RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Life Sciences and … |
| FIP | FTAI Infrastructure Inc. focuses on acquiring, developing, and operating assets and businesses that represent infrastructure for customers in the transportation and energy industries. It operates a multi-modal crude oil and … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Tejon Ranch
A-Score
1-Year Total Return ->
🥈
RCM Technologies
A-Score
1-Year Total Return ->
🥉
FTAI Infrastructure
A-Score
1-Year Total Return ->
4
Mammoth Energy Services
A-Score
1-Year Total Return ->
5
India Globalization Capital
A-Score
1-Year Total Return ->
6
